Carbazole antibiotics synthesis in a Streptomyces tendae bald mutant, created by acriflavine treatment.
Acriflavine treatment on Streptomyces tendae generated a bald mutant (bld-1) with an altered antibiotic pattern. The parental strain produced nikkomycins and juglomycins, whereas the mutant bld-1 was only capable of juglomycin synthesis. The existence of a mutant defective in morphogenesis and in nikkomycin biosynthesis suggests a common regulation of these processes. An interesting finding of this study is that mutant bld-1 produced two carbazole derivatives, hitherto never seen in cultures of the parental strain. It seems likely that the DNA intercalating dye acriflavine, by mutagenesis, had activated cryptic genes which are involved in carbazole synthesis. The two carbazole derivatives were identified as the neuronal cell protecting compounds CS-79B and carquinostatin A, recently isolated from a wild-type of S. exfoliatus. We found that both substances showed antibacterial activity.
Institut für Systemdynamik und Regelungstechnik, Universität Stuttgart, Germany. grammel@isr.uni-stuttgart.de
H
H
Grammel
H
H
Wolf
E D
ED
Gilles
F
F
Huth
H
H
Laatsch
D000167:Acriflavine / Q000494:pharmacology; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D002227:Carbazoles / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009024:Morphogenesis; D016296:Mutagenesis; D009285:Naphthoquinones / Q000378:metabolism / Q000494:pharmacology; D018696:Neuroprotective Agents; D013302:Streptomyces / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; C113605:CS 79B; D002227:Carbazoles; D009285:Naphthoquinones; D018696:Neuroprotective Agents; C113606:carquinostatin A; D000167:Acriflavine; C001492:juglomycin; C011952:nikkomycin